Otsuka Holdings
$21.14 B
Share price
Change (1 day)
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Revenue for Otsuka Holdings (4578.T)

Revenue in 2023 (TTM): $13.97 B

According to Otsuka Holdings 's latest financial reports the company's current revenue (TTM) is $13.97 B. In 2022 the company made a revenue of $13.02 B a decrease over the years 2021 revenue that were of $13.37 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Otsuka Holdings from 2010 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$13.97 B7.26%
2022$13.02 B-2.61%
2021$13.37 B-0.3%
2020$13.41 B4.72%
2019$12.81 B9.42%
2018$11.70 B6.04%
2017$11.04 B0.38%
2016$11.00 B-8.1%
2015$11.97 B
2013$14.15 B-1.07%
2012$14.30 B-0.08%
2011$14.31 B12.13%
2010$12.76 B